Your browser doesn't support javascript.
loading
Renoprotective Effect of Yiqi Yangyin Huayu Tongluo Formula against Diabetic Nephropathy in Diabetic Rats.
Wang, Feng-Li; Wang, Yue-Hua; Han, Lin; An, Hai-Yan; Zhang, Jiang-Hua; Zhang, Xue-Yun; Chen, Zhi-Qiang; Qin, Jian-Guo.
Affiliation
  • Wang FL; Central Laboratory, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China.
  • Wang YH; Department of Nephropathy, Hebei Medical University Third Hospital, Shijiazhuang, Hebei 050081, China.
  • Han L; School of Basic Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
  • An HY; Department of Nephropathy, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China.
  • Zhang JH; School of Integrated Traditional Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, China.
  • Zhang XY; School of Integrated Traditional Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, China.
  • Chen ZQ; Department of Nephropathy, Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei 050017, China.
  • Qin JG; Department of Nephropathy, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China.
Article in En | MEDLINE | ID: mdl-30622601
Diabetic nephropathy is developed in 20-40% of patients with diabetes mellitus, and patients with diabetic nephropathy require dialysis and renal transplantation. Traditional Chinese medicine has been widely used in treating patients with diabetic nephropathy in China. However, the detailed mechanisms of traditional Chinese medicine remain unclear. Yiqi Yangyin Huayu Tongluo formula (ZY formula) is a traditional Chinese medicinal formula. Here, we demonstrated kidney protective effect of ZY formula on the rats with diabetic nephropathy. The therapeutic effect of ZY formula on the diabetic nephropathy was almost the same as that of Irbesartan, which proved to have excellent curative effects on diabetic nephropathy. We also demonstrated the mechanism of ZY formula effect on the diabetic nephropathy. First, we validated that the activation of ROS-JNK signaling pathway in diabetic rats could be reduced by ZY. Furthermore, collagen I expression could be downregulated by ZY formula treatment. Meanwhile, cell apoptosis in the kidney of diabetic rats could be alleviated by ZY formula.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Evid Based Complement Alternat Med Year: 2018 Document type: Article Affiliation country: China Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Evid Based Complement Alternat Med Year: 2018 Document type: Article Affiliation country: China Country of publication: United States